MYND.AI INC (MYND)

US6289881079 - ADR

1.36  +0.1 (+7.94%)

After market: 1.35 -0.01 (-0.74%)

Fundamental Rating

2

Overall MYND gets a fundamental rating of 2 out of 10. We evaluated MYND against 66 industry peers in the Diversified Consumer Services industry. MYND may be in some trouble as it scores bad on both profitability and health. MYND is quite expensive at the moment. It does show a decent growth rate.



1

1. Profitability

1.1 Basic Checks

MYND had negative earnings in the past year.
In the past 5 years MYND reported 4 times negative net income.
In multiple years MYND reported negative operating cash flow during the last 5 years.

1.2 Ratios

Looking at the Return On Assets, with a value of -11.69%, MYND is doing worse than 64.06% of the companies in the same industry.
The Return On Equity of MYND (-49.14%) is worse than 68.75% of its industry peers.
Industry RankSector Rank
ROA -11.69%
ROE -49.14%
ROIC N/A
ROA(3y)-19.42%
ROA(5y)-14.26%
ROE(3y)-63.65%
ROE(5y)-50.69%
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

The Gross Margin of MYND (24.94%) is worse than 81.25% of its industry peers.
In the last couple of years the Gross Margin of MYND has grown nicely.
The Profit Margin and Operating Margin are not available for MYND so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 24.94%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5Y8.8%

1

2. Health

2.1 Basic Checks

MYND does not have a ROIC to compare to the WACC, probably because it is not profitable.
MYND has more shares outstanding than it did 1 year ago.
The number of shares outstanding for MYND has been increased compared to 5 years ago.
MYND has a worse debt/assets ratio than last year.

2.2 Solvency

MYND has an Altman-Z score of -0.34. This is a bad value and indicates that MYND is not financially healthy and even has some risk of bankruptcy.
With a Altman-Z score value of -0.34, MYND is not doing good in the industry: 70.31% of the companies in the same industry are doing better.
A Debt/Equity ratio of 0.81 indicates that MYND is somewhat dependend on debt financing.
With a Debt to Equity ratio value of 0.81, MYND is not doing good in the industry: 73.44% of the companies in the same industry are doing better.
Industry RankSector Rank
Debt/Equity 0.81
Debt/FCF N/A
Altman-Z -0.34
ROIC/WACCN/A
WACC8.29%

2.3 Liquidity

MYND has a Current Ratio of 1.22. This is a normal value and indicates that MYND is financially healthy and should not expect problems in meeting its short term obligations.
The Current ratio of MYND (1.22) is worse than 62.50% of its industry peers.
MYND has a Quick Ratio of 1.22. This is a bad value and indicates that MYND is not financially healthy enough and could expect problems in meeting its short term obligations.
Looking at the Quick ratio, with a value of 1.00, MYND is doing worse than 65.63% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.22
Quick Ratio 1

4

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 88.14% over the past year.
Looking at the last year, MYND shows a very strong growth in Revenue. The Revenue has grown by 727.13%.
MYND shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 21.45% yearly.
EPS 1Y (TTM)88.14%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-192.22%
Revenue 1Y (TTM)727.13%
Revenue growth 3Y113.66%
Revenue growth 5Y21.45%
Sales Q2Q%-25.4%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for MYND. In the last year negative earnings were reported.
Industry RankSector Rank
PE N/A
Fwd PE N/A

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

4

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 4138.23%, MYND is a good candidate for dividend investing.
The stock price of MYND dropped by -52.94% in the last 3 months. With lower prices the dividend yield is higher, but it may be a sign investors do not trust the long term dividend.
Compared to an average industry Dividend Yield of 544.94, MYND pays a better dividend. On top of this MYND pays more dividend than 100.00% of the companies listed in the same industry.
MYND's Dividend Yield is rather good when compared to the S&P500 average which is at 2.22.
Industry RankSector Rank
Dividend Yield 4138.23%

5.2 History

MYND does not have a reliable dividend history as it only pays dividend since a couple or years.
Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years0

5.3 Sustainability

DPN/A
EPS Next 2YN/A
EPS Next 3YN/A

MYND.AI INC

NYSEARCA:MYND (10/11/2024, 8:15:35 PM)

After market: 1.35 -0.01 (-0.74%)

1.36

+0.1 (+7.94%)

Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupConsumer Services
GICS IndustryDiversified Consumer Services
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap62.08M
Analysts
Price Target
Dividend
Industry RankSector Rank
Dividend Yield 4138.23%
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S
P/FCF
P/OCF
P/B
P/tB
EV/EBITDA
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -11.69%
ROE -49.14%
ROCE
ROIC
ROICexc
ROICexgc
OM N/A
PM (TTM) N/A
GM 24.94%
FCFM
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover1.28
Health
Industry RankSector Rank
Debt/Equity 0.81
Debt/FCF
Debt/EBITDA
Cap/Depr
Cap/Sales
Interest Coverage
Cash Conversion
Profit Quality
Current Ratio 1.22
Quick Ratio 1
Altman-Z
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
High Growth Momentum
Growth
EPS 1Y (TTM)88.14%
EPS 3YN/A
EPS 5Y
EPS Q2Q%
EPS Next YN/A
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)727.13%
Revenue growth 3Y113.66%
Revenue growth 5Y
Sales Q2Q%
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y